Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $35.61B · View financials
Decision snapshot: SAM stock price vs ALNY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ALNY's multiple
Needs ALNY P/E.
Implied fair value · at SAM's multiple
Needs SAM P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SAM FY 2025 (ended Dec 27, 2025) · ALNY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 90% equity / 10% debt · EV / Revenue 10.25x · EV / EBITDA 63.81x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
THE BOSTON BEER COMPANY, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ALNYLAM PHARMACEUTICALS, INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.04x
5.22x
Net debt / EBITDA
Leverage against operating earnings
-0.74x
4.13x
Cash and equivalents
Liquid reserves on the balance sheet
$223.38M
$1.66B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MOLSON COORS BEVERAGE CO
SAM vs TAP
Anheuser-Busch InBev SA/NV
SAM vs BUD
CONSTELLATION BRANDS, INC.
SAM vs STZ
Tilray Brands, Inc.
SAM vs TLRY
Moderna, Inc.
SAM vs MRNA
Sarepta Therapeutics, Inc.
SAM vs SRPT
VERTEX PHARMACEUTICALS INC / MA
SAM vs VRTX
BioNTech SE
SAM vs BNTX
ACADIA PHARMACEUTICALS INC
SAM vs ACAD
$33.48M
$4.12B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
